Previous Close | 86.45 |
Open | 87.20 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 800 |
Day's Range | 85.38 - 87.06 |
52 Week Range | 60.57 - 96.12 |
Volume | |
Avg. Volume | 4,026,537 |
Market Cap | 51.73B |
Beta (5Y Monthly) | 1.07 |
PE Ratio (TTM) | 37.37 |
EPS (TTM) | 2.30 |
Earnings Date | Apr 25, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 94.28 |
Universal Health's (UHS) Q1 results are expected to be aided by growing patient volumes and surgical cases, partly offset by increased expenses.
Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.